• PMS and GPR30/PI3K/AKT Signaling in Osteoporosis

  2026-08-26

  Wu and colleagues integrated network pharmacology, intracellular exposure analysis, zebrafish pharmacology, and MC3T3-E1 cell experiments to investigate how the low-concentration combination PMS may counter osteoporosis. Their results implicate GPR30-linked PI3K/AKT signaling in enhanced osteoblastic activity, while antagonist experiments provide pharmacological support without establishing GPR30 as the only pathway involved.

• Berbamine Hydrochloride: NF-κB Research Guide

  2026-08-25

  Berbamine hydrochloride is a research isoquinoline alkaloid derivative described as an NF-κB activity inhibitor, with product-reported cytotoxicity benchmarks in KU812 and HepG2 models. This guide separates those catalog measurements from the independent HCC ferroptosis mechanism reported by Wang et al.

• BCECF for Extracellular pH in Efferocytosis

  2026-08-25

  Learn how BCECF converts extracellular proton dynamics into a ratiometric readout for macrophage, ion-transport, and neuropathic-pain experiments. This workflow emphasizes calibration, compartment control, and troubleshooting so pH changes can be interpreted alongside efferocytosis and inflammatory signaling rather than mistaken for them.

• Gefitinib (ZD1839) in Gastric Cancer Assembloids

  2026-08-24

  Use Gefitinib (ZD1839) to connect EGFR pathway inhibition with patient-specific tumor–stroma biology in gastric cancer assembloids. This workflow emphasizes matched organoids, stromal context, phospho-signaling readouts, and troubleshooting when 3D models blunt apparent drug sensitivity.

• Diminazene Aceturate: Assay Reliability

  2026-08-23

  Diminazene Aceturate, SKU B1729, can support trypanosome parasite research and carefully controlled ACE2 activation research when formulation, vehicle effects, and assay interpretation are managed explicitly. This scenario-based guide connects product specifications with practical viability, cytotoxicity, and mitochondrial biogenesis workflows.

• AMG 487: Reframing CXCR3 Translation

  2026-08-22

  AMG 487 is a selective CXCR3 antagonist that helps translational researchers separate receptor-level chemokine signaling from macrophage-state effects, migration, and inflammatory phenotypes. This article connects quantitative assay design with the context-dependent CXCL10–CXCR3 biology reported in macrophage and acute lung injury research.

• Galectin-1–FIP200 Axis in Hepatic Steatosis

  2026-08-21

  A 2026 study identifies galectin-1 as an upstream inhibitor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through direct binding to FIP200. By combining mouse models, proteomics, structural mapping, binding analysis, and interaction-disrupting mutations, the work defines the Gal-1–FIP200 axis as a mechanistic target for metabolic liver disease research.

• Caspase-4, Pyroptosis, and Translational Strategy

  2026-08-21

  A mechanistic and strategic guide to using caspase-4 activity as a quantitative bridge between inflammatory signaling, pyroptosis, and emerging organelle-targeted cancer therapies.

• OATP1B3 N-Glycosylation and Surface Expression

  2026-08-20

  The reference study maps six N-glycosylation sites on human OATP1B3 and shows that this transporter is more extensively glycosylated than the closely related OATP1B1. Its experiments distinguish a major role for combined N-glycan loss in endoplasmic-reticulum retention and surface-expression failure from a more selective effect on transport turnover.

• Lamotrigine: From Ion Channels to Cardiotoxicity

  2026-08-20

  Lamotrigine research can move beyond sodium-channel blockade by pairing ion-channel perturbation with functional and transcriptomic readouts. This article shows how B2249 supports more interpretable CNS, cardiac, and epilepsy-induced arrhythmia studies.

• Phosphatase Inhibitor Cocktail 1: Signal Fidelity

  2026-08-19

  Phosphatase Inhibitor Cocktail 1 helps preserve phosphorylation-dependent information during sample preparation. This article connects K1012 use with assay interpretation, using a recent HPV-positive HNSCC study to show why biochemical signal preservation and biological heterogeneity must be evaluated together.

• AMG 487: Reading CXCR3 Signaling in Context

  2026-08-19

  AMG 487 is a selective CXCR3 antagonist for separating chemokine receptor signaling from cell-state effects. This guide connects pharmacology, macrophage-state biology, assay design, and translational limitations to improve interpretation of CXCR3 experiments.

• AMG 487 for Reliable CXCR3 Assays

  2026-08-18

  Learn how AMG 487 (SKU B3266) can strengthen CXCR3-focused migration, calcium mobilization, macrophage-polarization, and viability workflows. This scenario-based guide connects quantitative pharmacology with practical solvent, control, storage, and interpretation decisions.

• Liproxstatin-1: Ferroptosis Inhibitor Guide

  2026-08-18

  Liproxstatin-1 is a small-molecule ferroptosis inhibitor that suppresses lipid peroxidation and protects selected GPX4-deficient cell models. Product data report an IC50 of 22 nM in an RSL3-induced cell-death assay and activity in a conditional Gpx4 mouse model.

• Network Medicine Identifies Apigenin for Alzheimer’s

  2026-08-17

  A 2025 study used network proximity analysis to screen flavonoids against Alzheimer’s disease targets and identified Apigenin as the strongest candidate among experimentally tested compounds. Cell-based validation linked its neuroprotective activity to mitochondrial preservation, reduced apoptosis, AKT/NF-κB pathway modulation, and suppression of microglial inflammation.

455 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page